TABLE 2:
Comparison of secondary clinical outcomes in the EKOS study (all patients) versus the PROACT II study
| Secondary 90-Day Outcome | EKOS Study | PROACT II Study |
|---|---|---|
| mRS score ≤ 1, % | 14 | 26 |
| mRS score ≤ 2, % | 43 | 40 |
| mRS score ≤ 3, % | 57 | |
| BI ≥ 90, % | 36 | 41 |
| BI ≥ 60, % | 50 | 54 |
| NIHSS score ≤ 1, % | 14 | 18 |
| NIHSS score ≤ 4, % | 50 | |
| Decrease in NIHSS score ≥ 50%, % | 57 | 50 |
| Symptomatic intracranial hemorrhage, % | 14 | 10 |
| Mortality rate, % | 36 | 25 |
| Total no. of patients | 14 | 104 |
| Average time to treatment, h | 5.52 | 4.70 |
| Average time to lysis, min | 40 | NA |
Note.—NA indicates not applicable.